Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Midline granuloma. A clinical case report]

P P De Gioanni1, G F Bosco, R Modica

  • 1Divisione di Chirurgia Maxillo-Facciale, Università degli Studi di Torino.

Minerva Stomatologica
|March 1, 1993
PubMed
Summary

Granuloma gangraenescens, a rare destructive syndrome affecting the facial midline, presents as a progressive, necrotizing lesion. High-dose radiation is considered the primary treatment for this condition.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical presentation and outcomes of sporadic neuroendocrine neoplasms in young adults.

European journal of endocrinology·2026
Same author

From diabetes to tumor growth: unravelling the impact of glucose-lowering therapies.

Endocrine·2026
Same author

Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET).

ESMO open·2025
Same author

Functioning neuroendocrine tumors (NET): Minimum requirements for a NET specialist.

Cancer treatment reviews·2025
Same author

A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial.

ESMO open·2024
Same author

Authorship of Italian medical literature on neuroendocrine neoplasms: any gender gap?

Journal of endocrinological investigation·2024

Area of Science:

  • Pathology
  • Otolaryngology
  • Oncology

Background:

  • Granuloma gangraenescens, also known as "midline granuloma" or idiopathic midline destructive syndrome, is a rare and aggressive clinical entity.
  • It is characterized by a progressive, necrotizing destructive process primarily affecting the facial midline, including the nose, paranasal sinuses, and palate.
  • This syndrome can mimic symptoms of various infective, malignant, or autoimmune diseases, complicating diagnosis.